Morning Medical with Dr. Chow
A daily update covering the latest medical & health news from around the world using artificial intelligence. Doctor Chi-Ming Chow is a family physician, general internist, and cardiologist. He is also a Professor of Medicine at the University of Toronto.
Chronic Pain Breakthrough, Ontario Drug Site Closure, and New COVID Variant BA.3.2
In this episode, Dr. Chi-Ming Chow delves into a range of topics. He explores a breakthrough in chronic back pain treatment and new research on parathyroid hormone. The episode also examines Ontario's decision to close supervised drug consumption sites and its public health implications. Dr. Chow updates listeners on the new COVID-19 variant BA.3.2 in the US and its potential impact. Additionally, he discusses the effects of the US oil embargo on the Cuban healthcare system and concludes with insights on the landmark trial against Meta and YouTube regarding social media addiction.
Key Points
- Parathyroid hormone shows promise in addressing chronic back pain by reversing nerve growth in spinal degeneration.
- Ontario's decision to close supervised drug consumption sites has sparked significant debate and concern among health-care workers and former mayors.
- The BA.3.2 COVID-19 variant's immune escape capability underscores the need for continuous genomic surveillance to monitor its impact on public health.
Chapters
| 0:00 | |
| 0:18 | |
| 2:51 | |
| 6:24 | |
| 9:24 | |
| 13:28 | |
| 15:16 |
Transcript
Loading transcript...
- / -